Document ID: chunk:federal_register_of_legislation:F2025C00036:clause:5a_2a
Version: federal_register_of_legislation:F2025C00036
Segment Type: clause
Provision Reference: sch 5A cl 2A
Character Range: 529326–531112

2A        Therapeutic goods that are medicinal cannabis products manufactured in Australia under a licence granted under Part 3‑3 of the Act and are held under the direct control of the sponsor, until a decision is made under section 25 or 26 of the Act about the goods                                                                                                                     the sponsor must:
                                                                                                                                                                                                                                                                                                                                                                                                  (a) keep records about the source of the goods; and
                                                                                                                                                                                                                                                                                                                                                                                                  (b) if requested by the Secretary, give the records to the Secretary; and
                                                                                                                                                                                                                                                                                                                                                                                                  (c) have lodged an application under section 23 of the Act for the goods before their manufacture